Is there a relationship between blood pressure and intraocular pressure? An experimental study in hypertensive rats

Current Eye Research

Volumn 33, Issue 4, 2008, Pages 325-332

  Vaajanen, A ^a   Mervaala, E ^a,b   Oksala, O ^a   Vapaatalo, H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Animal model; Blood pressure; dTGR; Intraocular pressure; SHR

Indexed keywords

ANGIOTENSINOGEN; OFTAN OBUCAIN; OLMESARTAN; OXYBUPROCAINE; RENIN; UNCLASSIFIED DRUG; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; EXPERIMENTAL STUDY; FOLLOW UP; INTRAOCULAR PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; SYSTOLIC BLOOD PRESSURE; TONOMETRY; TRANSGENIC RAT; WISTAR KYOTO RAT;

ANESTHESIA, GENERAL; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSINOGEN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD PRESSURE; HUMANS; HYPERTENSION; INTRAOCULAR PRESSURE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RENIN;

EID: 41949129627     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680802011679     Document Type: Article

References (41)

1. Carretero OA, Oparil S. Essential hypertension. Part I: Definition and etiology. Circulation. 2000;101:329-335.
2. Kearney P, Whelton M, Reynolds K, et al. Worldwide prevalence of hypertension: A systematic review. J Hypertens. 2004;22:11-19.
3. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
4. Leighton DA, Phillips CI. Systemic blood pressure in open-angle glaucoma, low-tension glaucoma, and the normal eye. Br J Ophthalmol. 1972;56:447-453.
5. Tielsch JM, Katz J, Sommer A, et al. Hypertension, perfusion pressure, and primary open angle glaucoma. A population-based assessment. Arch Ophthalmol. 1995;113:216-221.
6. Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: The Egna-Neumarkt Study. Ophthalmology. 2000;107:1287-1293.
7. Dielemans I, Vingerling JR, Algra D, et al. Primary openangle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population: The Rotterdam Study. Ophthalmology.1995;102:54-60.
8. Klein BE, Klein R, Knudtson MD. Intraocular pressure and systemic blood pressure: Longitudinal perspective: The Beaver Dam Eye Study. Br J Ophthalmol. 2005;89:284-287.
9. Mitchell P, Lee AJ, Rochtcina E, Wang JJ. Open-angle glaucoma and systemic hypertension: The Blue Mountains Eye Study. J Glaucoma. 2004;13:319-326.
10. Leske MC, Connell AM, Wu SY, et al. Risk factors for open angle glaucoma: The Barbados Eye Study. Arch Ophthalmol.1995;113:918-924.
11. Sommer A. Glaucoma risk factors observed in the Baltimore Eye Survey. Curr Opin Ophthalmol. 1996;7:93-98.
12. Kontiola AI, Goldblum D, Mittag T, Danias J. The induction/impact tonometer: A new instrument to measure intraocular pressure in the rat. Exp Eye Res. 2001;73:781-785.
13. Wang WH, Millar JC, Pang IH, et al. Noninvasive measurement of rodent intraocular pressure with a rebound tonometer. Invest Ophthalmol Vis Sci. 2005;46:4617-4621.
14. Goldblum D, Kontiola AI, Mittag T, et al. Non-invasive determination of intraocular pressure in the rat eye. Comparison of an electronic tonometer (Tono-Pen) and a rebound (impact probe) tonometer. Graef Arch Clin Exp Ophthalmol. 2002;240:942-946.
15. Pease ME, Hammond JC, Quigley HA. Manometric calibration and comparison of TonoLab and Tono-Pen tonometers in rats with experimental glaucoma and in normal mice. J Glaucoma. 2006;15:512-519.
16. Louhelainen M, Merasto S, Finckenberg P, et al. Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats. J Hypertens. 2006;24:947-956.
17. Mervaala E, Müller DN, Schmidt F, et al. Blood pressure independent effects in rats with human renin and angiotensinogen genes. Hypertension. 2000;35:587-594.
18. Pilvi TK, Jauhiainen T, Cheng ZJ, et al. Lupin protein attenuates the development of hypertension and normalizes the vascular function of NaCl-loaded Goto-Kakizaki rats. J Physiol Pharmacol. 2006;57:167-176.
19. StataCorp. 2007. Stata Statistical Software: Release 10. College Station, TX: StataCorp LP.
20. Liu JH, Kripke DF, Hoffman RE, et al. Nocturnal elevation of IOP in young adults. Invest Ophthalmol Vis Sci. 1998;39:2707-2712.
21. Liu JH, Kripke DF, Hoffman RE, et al. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci. 1999;40:2912-2917.
22. Krishna R, Mermoud A, Baerveldt G, Minckler DS. Circadian rhythm of intraocular pressure: A rat model. Ophthalmic Res. 1995;27:163-167.
23. Sugimoto E, Aihara M, Ota T, Araie M. Effect of light cycle on 24-hour pattern of mouse intraocular pressure. J Glaucoma. 2006;15:505-511.
24. Moore CG, Johnson EC, Morrison JC. Circadian rhythm of intraocular pressure in the rat. Curr Eye Res. 1996;15:185-191.
25. Mermoud A, Baerveldt G, Minckler DS, et al. Intraocular pressure in Lewis rats. Invest Ophthalmol Vis Sci. 1994;35:2455-2460.
26. Xu L, Wang H, Wang Y, Jonas JB. Intraocular pressure correlated with arterial blood pressure: The Beijing Eye Study. Am J Ophthalmol. 2007;144:461-462.
27. Gherghel D, Hosking SL, Orgü l S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol. 2004;49:491-508.
28. Costagliola C, Verolino M, de Rosa ML, et al. Effect of oral losartan potassium on intraocular pressure in normotensive and glaucomatous human subjects. Exp Eye Res. 2000;71:167-171.
29. Costagliola C, Di Benedetto R, De Caprio L, et al. Effect of oral captopril (SQ 14225) on intraocular pressure in man. Eur J Ophthalmol. 1995;5:19-25.
30. Watkins RW, Baum T, Cedeno K, et al. Topical ocular hypotensive effects of the novel angiotensin converting enzyme inhibitor SCH 33861 in conscious rabbits. J Ocul Pharmacol. 1987;3:295-307.
31. Vogh BP, Godman DR. Effects of inhibition of angiotensin converting enzyme and carbonic anhydrase on fluid production by ciliary process, choroid plexus, and pancreas. J Ocul Pharmacol. 1989;5:303-311.
32. Wang RF, Podos SM, Mittag TW, Yokoyoma T. Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes. Exp Eye Res. 2005;80:629-632.
33. Inoue T, Yokoyoma T, Mori Y, et al. The effect of topical CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure and aqueous humor dynamics in rabbits. Curr Eye Res. 2001;23:133-138.
34. Shah GB, Sharma S, Mehta AA, Goyal RK. Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma. J Cardiovasc Pharmacol. 2000;36:169-175.
35. Constad WH, Fiore P, Samson C, Cinotti AA. Use of an angiotensin- converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma. Am J Ophthalmol. 1988;105:674-677.
36. Danser AHJ, Derkx FHM, Admiraal PJJ, et al. Angiotensin levels in the eye. Invest Ophthalmol Vis Sci. 1994;35:1008-1018.
37. Sramek SJ, Wallow IHL, Tewksbury DA, et al. An ocular renin-angiotensin system. Immunohistochemistry of angiotensinogen. Invest Ophthalmol Vis Sci. 1992;33:1627-1632.
38. Wagner J, Danser JAH, Derkx FH, et al. Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin-converting enzyme mRNA expression in the human eye: Evidence for an intraocular renin-angiotensin system. Br J Ophthalmol. 1996;0:159-163.
39. Savaskan E, Loffler KU, Meier F, et al. Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II, and AT1 receptor in human ocular tissues. Ophthalmic Res. 2004;36:312-320.
40. Hoy Y, Delamere NA. Influence of ANG II on cytoplasmic sodium in cultured rabbit nonpigmented ciliary epithelium. Am J Physiol Cell Physiol. 2002;283:552-559.
41. Vaajanen A, Vapaatalo H, Kautiainen H, Oksala O. Angiotensin (1-7) reduces intraocular pressure in the normotensive rabbit eye. Invest Ophthalmol Vis Sci. 2008; in press.